These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30798469)

  • 21. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis.
    Takeyama Y; Tsuchiya N; Kunimoto H; Fukunaga A; Sakurai K; Hirano G; Yokoyama K; Morihara D; Anan A; Irie M; Shakado S; Sohda T; Sakisaka S
    Hepatol Res; 2015 Oct; 45(10):E108-14. PubMed ID: 25560223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30° Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis.
    Jeon I; Cho ES; Kim JH; Kim DJ; Yu JS; Chung JJ
    PLoS One; 2016; 11(12):e0167701. PubMed ID: 27936106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
    Talakic E; Steiner J; Kalmar P; Lutfi A; Quehenberger F; Reiter U; Fuchsjäger M; Schöllnast H
    Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI.
    Haimerl M; Verloh N; Zeman F; Fellner C; Müller-Wille R; Schreyer AG; Stroszczynski C; Wiggermann P
    PLoS One; 2013; 8(12):e85658. PubMed ID: 24392025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.
    Kanki A; Tamada T; Higaki A; Noda Y; Tanimoto D; Sato T; Higashi H; Ito K
    Magn Reson Imaging; 2012 Apr; 30(3):356-60. PubMed ID: 22227353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of biliary ductal anatomy in potential living liver donors: comparison between MRCP and Gd-EOB-DTPA-enhanced MRI.
    Santosh D; Goel A; Birchall IW; Kumar A; Lee KH; Patel VH; Low G
    Abdom Radiol (NY); 2017 Oct; 42(10):2428-2435. PubMed ID: 28474177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the biliary tract by virtual ultrasonography constructed by gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.
    Koizumi Y; Hirooka M; Ochi H; Tokumoto Y; Takechi M; Hiraoka A; Ikeda Y; Kumagi T; Matsuura B; Abe M; Hiasa Y
    J Med Ultrason (2001); 2015 Apr; 42(2):185-93. PubMed ID: 26576571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.
    Tsuda N; Okada M; Murakami T
    Eur J Radiol; 2010 Jan; 73(1):137-42. PubMed ID: 19026502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
    Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
    World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Balanced MR cholangiopancreatography with motion-sensitised driven-equilibrium (MSDE) preparation: feasibility of Gd-EOB-DTPA-enhanced biliary examination.
    Nakayama T; Yoshiura T; Nishie A; Asayama Y; Ishigami K; Kakihara D; Takayama Y; Hatakenaka M; Obara M; Honda H
    Clin Radiol; 2016 Dec; 71(12):1284-1288. PubMed ID: 27146898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
    Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
    Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced MR cholangiography: comparison of Gd-EOB-DTPA and Mn-DPDP in healthy volunteers.
    Bae K; Na JB; Choi DS; Cho JM; Choi HC; Jeon KN; Park MJ; Choi HY; Kim JE; Chung SH
    Br J Radiol; 2012 Sep; 85(1017):1250-4. PubMed ID: 22553292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study.
    Li J; Cao B; Bi X; Chen W; Wang L; Du Z; Zhang X; Yu X
    Radiol Med; 2021 Sep; 126(9):1149-1158. PubMed ID: 34105102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
    Tsuda N; Okada M; Murakami T
    Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers.
    Tamada T; Ito K; Sone T; Kanki A; Sato T; Higashi H
    Eur J Radiol; 2011 Dec; 80(3):e207-11. PubMed ID: 20869827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.
    Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
    Abdom Radiol (NY); 2017 Sep; 42(9):2272-2278. PubMed ID: 28396918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.